Shenzhen, Guangdong, China The standard case for the fund is to invest in rounds with 5 partakers. Despite the QianHai Equity Investment, startups are often financed by Zhongjin Qichen, Tasly Pharmaceutical, THG Ventures. The meaningful sponsors for the fund in investment in the same round are Zhongjin Qichen, WTT Investment, Tasly Pharmaceutical.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The top amount of exits for fund were in 2018. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2018.
Among the various public portfolio startups of the fund, we may underline Ascletis, Bellen Among the most successful fund investment fields, there are Biotechnology, Product Research. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups.
Related Funds
| Fund Name | Location |
| 8-Bit Capital | California, San Francisco, United States |
| Aditya Birla Financial Services | - |
| At One Ventures | - |
| Bank of India | Bandra, India, Maharashtra |
| Bekaert | Belgium, West-Vlaanderen, Zwevegem |
| CanCode | - |
| Daying Capital | China, Guangdong, Shenzhen |
| Eastern Pacific Accelerator | Central Region, Singapore, Singapore |
| Jerry Pruttz Holding Ab | - |
| JointForce Fund | Beijing, China, Haidian |
| Meakem Becker Venture Capital | Pennsylvania, Sewickley, United States |
| Orgain | California, Irvine, United States |
| Orient Hontai Capital | Beijing, Beijing, China |
| Shenlian Touzi | - |
| Stockton & Partners | Pennsylvania, Philadelphia, United States |
| Swedish Energy Agency | Eskilstuna, Sodermanlands Lan, Sweden |
| Vitesse Semiconductor | California, Camarillo, United States |
| Zhonghui Guoji | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $17M | 19 Feb 2020 | Gansu | |||
Bellen | $30M | 27 Sep 2018 | Beijing | ||
Ascletis | $100M | 03 Jan 2017 | North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $17M | 19 Feb 2020 | Gansu | |||
Bellen | $30M | 27 Sep 2018 | Beijing | ||
Ascletis | $100M | 03 Jan 2017 | North Carolina, United States |
